📍#CLINICAL24 Feature
Current and emerging challenges in clinical microbiology
Clinical microbiology is at the heart of infectious disease diagnosis, providing the insights needed to support timely treatment decisions, infection control, and improved patient outcomes. As part of #CLINICAL24, SelectScience brings together leading clinical, laboratory, and industry experts to explore current and emerging challenges in microbiology, including antimicrobial resistance (AMR), antimicrobial stewardship, sepsis, tuberculosis, blood culture, rapid diagnostics, next-generation sequencing, molecular testing advances, and more. Discover the latest scientific developments, technology innovations, and expert perspectives shaping the future of infectious disease diagnostics below.
CLINICAL24 Forum: Finding the balance between rapid diagnostics and traditional microbiology
Sponsored by Oxoid Remel Microbiology
Register now to join leading experts as they explore how rapid diagnostic technologies and traditional microbiology can work together to deliver faster, more actionable results, strengthen antimicrobial stewardship and improve patient care. Hear practical perspectives on the latest advances, the continuing value of culture and susceptibility testing, and what the future holds for infection diagnosis, then put your questions to the panel during a live Q&A.
Carbapenem resistance in 2026: From rapid detection to actionable susceptibility results
Explore the evolving challenge of Gram-negative antimicrobial resistance with Professors Laurent Dortet and Axel Hamprecht. Through expert insights and practical case studies, discover how resistance-mechanism detection, phenotypic AST, and MIC testing work together to support actionable susceptibility reporting, helping laboratories adapt to emerging resistance patterns and evolving treatment options.
Register for webinar
Rapid AST: Speed is only part of the story
Explore how rapid antimicrobial susceptibility testing (AST) performs against some of the most challenging drug-resistant pathogens. This infographic highlights findings from a new comparative study evaluating QuickMIC® and EUCAST RAST, revealing key insights into speed, result availability, accuracy, and the role of rapid AST in supporting timely clinical decision-making and antimicrobial stewardship.
Download infographic
From emerging threats to diagnostic breakthroughs: A strategic look ahead in AMR
Don’t miss this chance to learn from industry professionals in a dynamic session filmed at ESCMID Global 2026. Brought to you by Danaher companies, Beckman Coulter Diagnostics and Cepheid, this session explores the role of emerging diagnostic modalities to combat the development and spread of antimicrobial resistance (AMR).
Watch webinar on demandThe clinical microbiology community
Clinical microbiology is central to the detection, diagnosis, and management of infectious diseases, helping laboratories and healthcare professionals respond to some of the most pressing challenges in modern medicine. From antimicrobial resistance (AMR) and sepsis to emerging pathogens and advances in molecular diagnostics, the field continues to evolve at pace.
Stay connected with the latest expert insights, scientific developments, and educational content from across the clinical microbiology community.
Want the latest news, interviews, webinars, and resources delivered straight to your inbox? Become a member for free here.
What will define a resilient infectious disease response over the next decade?
Stephanie Ibbotson of Diasorin explores how coordinated surveillance, diagnostics, regulation, reimbursement, and communication can strengthen infectious disease preparedness. Ibbotson highlights lessons from recent public health emergencies, the value of sustained laboratory infrastructure and early-warning systems, and the partnerships needed to translate rapid scientific innovation into equitable patient access and effective outbreak response.
Read article
MIC data and AST confidence shape modern AMR stewardship
Discover how antimicrobial stewardship programs are evolving beyond rapid results alone. In this expert interview, learn why access to accurate MIC data and confidence in antimicrobial susceptibility testing (AST) are becoming increasingly important for guiding treatment decisions, improving patient outcomes, and helping laboratories tackle the growing threat of antimicrobial resistance.
Read article
Can endotyping unlock precision medicine for sepsis and critical illness?
Join our expert speakers in this accredited webinar as they explore the scientific and clinical rationale behind endotyping in sepsis and critical illness.
Register for webinar
From Helicobacter pylori to the AMR crisis: Q&A with Professor Liang Wang
Discover how one of microbiology’s most significant breakthroughs, the discovery of Helicobacter pylori, laid the foundations for modern antimicrobial stewardship.
Register article
Rapid AST and sepsis management in real-world hospital settings
Leading experts explore how to bridge the gap between technological innovation and real-world adoption of rapid AST.
Watch webinar on demand
